Role of arginase in the male and female sexual arousal response

Journal of Nutrition

Volumn 134, Issue 10 SUPPL., 2004, Pages

  Kim, Noel N ^a   Christianson, David W ^b   Traish, Abdulmaged M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Arginase; Arginine; Erectile function; Genital hemodynamics; Nitric oxide synthase

Indexed keywords

2 AMINO 6 BORONOHEXANOIC ACID; ARGINASE; ARGININE; ARGININE GLUTAMATE; CITRULLINE; CYCLIC GMP; CYSTEINE DERIVATIVE; EFLORNITHINE; ENZYME INHIBITOR; HEXANOIC ACID DERIVATIVE; N(G) HYDROXYARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; OXYGEN; PHENTOLAMINE; S (2 BORONOETHYL)CYSTEINE; SEX HORMONE; UNCLASSIFIED DRUG; UREA; YOHIMBINE;

CATALYSIS; CLINICAL TRIAL; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; ERECTILE DYSFUNCTION; FEMALE; FIBROSIS; GENITAL SYSTEM; HEMODYNAMICS; HUMAN; HYDROLYSIS; IMMUNITY; MALE; NONHUMAN; PENILE BLOOD FLOW; PENIS; PENIS ERECTION; SEXUAL AROUSAL; SEXUAL FUNCTION; SIGNAL TRANSDUCTION; TISSUE GROWTH; VAGINA;

EID: 4744366908     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.10.2873s     Document Type: Conference Paper

References (85)

1. NIH consensus conference (1993) Impotence. NIH consensus development panel impotence. J. Am. Med. Assoc. 270: 83-90.
2. Laumann, E. O., Gagnon, J. H., Michael, R. T. & Michaels, S. (1994) The social organization of sexuality. University of Chicago Press, Chicago, IL.
3. Laumann, E. O., Paik, A. & Rosen, R. C. (1999) Sexual dysfunction in the United States: prevalence and predictors. J. Am. Med. Assoc. 281: 537-544.
4. Feldman, H., Goldstein, I., Hatzichristou, D., Krane, R. & McKinlay, J. (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J. Urol. 151: 54-61.
5. Lue, T. F. & Tanagho, E. A. (1987) Physiology of erection and pharmacological management of impotence. J. Urol. 137: 829-836.
6. Krane, R. J., Goldstein, I. & Saenz de Tejada, I. (1989) Impotence. N. Engl. J. Med. 321: 1648-1659.
7. Saenz de Tejada, I., Moroukian, P., Tessier, J., Kim, J. J., Goldstein, I. & Frohrib, D. (1991) Trabecular smooth muscle modulates the capacitor function of the penis. Studies on a rabbit model. Am. J. Physiol. 260: H1590-H1595.
8. Andersson, K-E. & Wagner, G. (1995) Physiology of penile erection. Physiol. Rev. 75: 191-236.
9. Giuliano, F., Allard, J., Compagnie, S., Alexandre, L., Droupy, S. & Bernabe, J. (2001) Vaginal physiological changes in a model of sexual arousal in anesthetized rats. Am. J. Physiol. 281: R140-R149.
10. Giuliano, F., Rampin, O. & Allard, J. (2002) Neurophysiology and pharmacology of female genital sexual response. J. Sex Marital. Ther. 28: 101-121.
11. Ignarro, L. J., Bush, P. A., Buga, G. M., Wood, K. S., Fukuto, J. M. & Rajfer, J. (1990) Nitric oxide and cyclic GMP formation upon electrical stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem. Biophys. Res. Commun. 170: 843-850.
12. Kim, N., Azadzoi, K. M., Goldstein, I. & Saenz de Tejada, I. (1991) A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J. Clin. Invest. 88: 112-118.
13. Kim, N., Vardi, Y., Padma-Nathan, H., Daley, J., Goldstein, I. & Saenz de Tejada, I. (1993) Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J. Clin. Invest. 91: 437-442.
14. Rajfer, J., Aronson, W. J., Bush, P. A., Dorey, F. J. & Ignarro, L. (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. New Engl. J. Med. 326: 90-94.
15. Burnett, A. L., Lowenstein, C. J., Bredt, D. S., Chang, T. S. & Snyder, S. H. (1992) Nitric oxide: a physiologic mediator of penile erection. Science 17: 401-403.
16. Saenz de Tejada, I., Goldstein, I., Azadzoi, K., Krane, R. J. & Cohen, R. A. (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. New Engl. J. Med. 320: 1025-1030.
17. Cartledge, J., Minhas, S. & Eardley, I. (2001) The role of nitric oxide in penile erection. Expert Opin. Pharmacother. 2: 95-107.
18. Bolotina, V. M., Najibi, S., Palacino, J. J., Pagano, P. J. & Cohen, R. A. (1994) Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853.
19. +-ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide. Br. J. Pharmacol. 116: 2201-2206.
20. Burnett, A. L. (1997) Nitric oxide in the penis: physiology and pathology. J. Urol. 157: 320-324.
21. Garban, H., Vernet, D., Freedman, A., Rajfer, J. & Gonzalez-Cadavid, N. (1995) Effect of aging on nitric oxide-mediated penile erection in rats. Am. J. Physiol. 268: H467-475.
22. Dahiya, R., Lin, A., Bakircioglu, M. E., Huang, S. T. & Lue, T. F. (1997) mRNA and protein expression of nitric oxide synthase and adrenoceptor alpha 1 in young and old rat penile tissues. Br. J. Urol. 80: 300-306.
23. Carrier, S., Nagaraju, P., Morgan, D. M., Baba, K., Nunes, L. & Lue, T. F. (1997) Age decreases nitric oxide synthase-containing nerve fibers in the rat penis. J. Urol. 157: 1088-1092.
24. Vernet, D., Cai, L., Garban, H., Babbitt, M. L., Murray, F. T., Rajfer, J. & Gonzalez-Cadavid, N. F. (1995) Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 136: 5709-5717.
25. El-Sakka, A. I., Lin, C. S., Chui, R. M., Dahiya, R. & Lue, T. F. (1999) Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model Int. J. Impot. Res. 11: 123-132.
26. Bivalacqua, T. J., Champion, H. C., Leungwattanakij, S., Yang, D. Y., Hyun, J. S., Abdel-Mageed, A. B., Sikka, S. C., Kadowitz, P. J. & Hellstrom, W. J. (2001) Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat. J. Androl. 22: 497-506.
27. Bivalacqua, T. J., Hellstrom, W. J., Kadowitz, P. J. & Champion, H. C. (2001) Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem. Biophys. Res. Commun. 18: 923-927.
28. De Angelis, L., Marella, M. A., Siniscalchi, M., Marino, L., Nappo, F., Giugliano, F., De Lucia, D. & Giugliano, D. (2001) Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia 44: 1155-1160.
29. Zorgniotti, A. W. & Lizza, E. F. (1994) Effect of large doses of the nitric oxide precursor, L-arginine, on erectile dysfunction. Int. J. Impot. Res. 6: 33-35.
30. Lebret, T., Herve, J. M., Gorny, P., Worcel, M. & Botto, H. (2002) Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction. Eur. Urol. 41: 608-613.
31. Chen, J., Wollman, Y., Chernichovsky, T., Iaina, A., Sofer, M. & Matzkin, H. (1999) Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int. 83: 269-273.
32. Klotz, T., Mathers, M. J., Braun, M., Bloch, W. & Engelmann, U. (1999) Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol. Int. 63: 220-223.
33. Moody, J. A., Vernet, D., Laidlaw, S., Rajfer, J. & Gonzalez-Cadavid, N. F. (1997) Effects of long-term oral administration of L-arginine on the rat erectile response. J. Urol. 158: 942-947.
34. Yildirim, S., Ayan, S., Sarioglu, Y., Gultekin, Y. & Butuner, C. (1999) The effects of long-term oral administration of L-arginine on the erectile response of rabbits with alloxan-induced diabetes. BJU Int. 83: 679-685.
35. Angulo, J., Cuevas, P., Fernandez, A., Gabancho, S. & Saenz de Tejada, I. (2001) Combination of phentolamine and L-arginine or sildenafil synergistically improves neurogenic relaxation of rabbit corpus cavernosum smooth muscle. Urology 57: 585-589.
36. Angulo, J., Cuevas, P., Fernandez, A., Gabancho, S., Allona, A., Martin-Morales, A., Moncada, I. & Saenz de Tejada, I. (2003) Activation and potentiation of the NO/cGMP pathway by NG-hydroxyl-L-arginine in rabbit corpus cavernosum under normoxic and hypoxic conditions and ageing. Br. J. Pharmacol. 138: 63-70.
37. Girerd, X. J., Hirsch, A. T., Cooke, J. P., Dzau, V. J. & Creager, M. A. (1990) L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ. Res. 67: 1301-1308.
38. Böger, R. H., Bode-Boge, S. M., Mugge, A., Kienke, S., Brandes, R., Dwenger, A. & Frolich, J. C. (1995) Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 117: 273-284.
39. Böger, R. H., Bode-Böger, S. M., Brandes, R. P., Phivthong-ngam, L., Bohme, M., Nafe, R., Mugge, A. & Frolich, J. C. (1997) Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation 96: 1282-1290.
40. Böger, R. H., Bode-Böger, S. M., Phivthong-ngam, L., Brandes, R. P., Schwedhelm, E., Mugge, A., Bohme, M., Tsikas, D. & Frolich, J. C. (1998) Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis 141: 31-43.
41. Phivthong-ngam, L., Bode-Böger, S. M., Böger, R. H., Bohme, M., Brandes, R. P., Mugge, A. & Frolich, J. C. (1998) Dietary L-arginine normalizes endothelin-induced vascular contractions in cholesterol-fed rabbits. J. Cardiovasc. Pharmacol. 32: 300-307.
42. Rossitch, E. Jr., Alexander, E., 3rd, Black, P. M. & Cooke, J. P. (1991) L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. J. Clin. Invest. 87: 1295-1299.
43. Drexler, H., Zeiher, A. M., Meinzer, K. & Just, H. (1991) Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 338: 1546-1550.
44. Cooke, J. P., Dzau, J. & Creager, A. (1991) Endothelial dysfunction in hypercholesterolemia is corrected by L-arginine. Basic Res. Cardiol. 86 (Suppl. 2): 173-181.
45. Pieper, G. M. & Peltier, B. A. (1995) Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J. Cardiovasc. Pharmacol. 25: 397-403.
46. Block, E. R., Herrera, H. & Couch, M. (1995) Hypoxia inhibits L-arginine uptake by pulmonary artery endothelial cells. Am. J. Physiol. 269: L574-L580.
47. Mitchell, J. A., Hecker, M., Anggard, E. E. & Vane, J. R. (1990) Cultured endothelial cells maintain their L-arginine level despite the continuous release of EDRF. Eur. J. Pharmacol. 182: 573-576.
48. Arnal, J. F., Munzel, T., Venema, R. C., James, N. L., Bai, C. L., Mitch, W. E. & Harrison, D. G. (1995) Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. J. Clin. Invest. 95: 2565-2572.
49. Hecker, M., Sessa, W. C., Harris, H. J., Anggard, E. E. & Vane, J. R. (1990) The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc. Natl. Acad. Sci. U.S.A. 87: 8612-8616.
50. Venema, R. C., Sayegh, H. S., Kent, J. D. & Harrison, D. G. (1996) Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases. J. Biol. Chem. 271: 6435-6440.
51. Liu, J., Garcia-Cardena, G. & Sessa, W. C. (1996) Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 35: 13277-13281.
52. Pollock, J. S., Forstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H., Nakane, M. & Murad, F. (1991) Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 88: 10480-10484.
53. Aisaka, K., Gross, S. S., Griffith, O. W. & Levi, R. (1989) L-arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. Biochem. Biophys. Res. Commun. 163: 710-717.
54. Taylor, P. D. & Poston, L. (1994) The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. Br. J. Pharmacol. 113: 801-808.
55. Creager, M. A., Gallagher, S. J., Girerd, X. J., Coleman, S. M., Dzau, V. J. & Cooke, J. P. (1992) L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 90: 1248-1253.
56. Berkowitz, D. E., White, R., Li, D., Minhas, K. M., Cernetich, A., Kim, S., Burke, S., Shoukas, A. A., Nyhan, D., Champion, H. C. & Hare, J. M. (2003) Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108: 2000-2006.
57. Chicoine, L. G., Paffett, M. L., Young, T. L. & Nelin, L. D. (2004) Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am. J. Physiol. Lung Cell Mol Physiol. (In press). E-pub available at: http://ajplung.physiology.org/cgi/reprint/00194.2003v1.pdf.
58. Mugge, A. & Harrison, D. G. (1991) L-arginine does not restore endothelial dysfunction in atherosclerotic rabbit aorta in vitro. Blood Vessels 28: 354-357.
59. Loscalzo, J. (2000) What do we know and don't know about L-arginine and NO? Circulation 101: 2126-2129.
60. McDonald, K. K., Zharikov, S., Block, E. R. & Kilberg, M. S. (1999) A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox." J. Biol. Chem. 272: 31213-31216.
61. Hein, T. W., Zhang, C., Wang, W., Chang, C. I., Thengchaisri, N. & Kuo, L. (2003) Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J. 17: 2328-2330.
62. Que, L. G., George, S. E., Gotoh, T., Mori, M. & Huang, Y. C. (2002) Effects of arginase isoforms on NO Production by nNOS. Nitric Oxide 6: 1-8.
63. Harrison, D. G. (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100: 2153-2157.
64. Ricciardolo, F. L. (2003) cNOS-iNOS paradigm and arginase in asthma. Trends Pharmacol. Sci. 24: 560-561.
65. Kim, N. N., Cox, J. D., Baggio, R. F., Emig, F. A., Mistry, S. K., Harper, S. L., Speicher, D. W., Morris, S. M. Jr., Ash, D. E., Traish, A. & Christianson, D. W. (2001) Probing erectile function: S-(2-boronoethyl)-L- cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum. Biochemistry 40: 2678-2688.
66. Cox, J. D., Kim, N. N., Traish, A. M. & Christianson, D. W. (1999) Arginase-boronic acid complex highlights a physiological role in erectile function. Nat. Struct. Biol. 6: 1043-1047.
67. Baggio, R., Cox, J. D., Harper, S. L., Speicher, D. W. & Christianson, D. W. (1999) A new chromophoric assay for arginase activity. Anal. Biochem. 276: 251-253.
68. 2-arginase by borate leads to the design of a transition state analogue inhibitor, 2(S)-amino-6-boronohexanoic acid. J. Am. Chem. Soc. 119: 8107-8108.
69. Baggio, R., Emig, F. A., Christianson, D. W., Ash, D. E., Chakder, S. & Rattan, S. (1999) Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor. J. Pharmacol. Exp. Ther. 290: 1409-1416.
70. Colleluori, D. M. & Ash, D. E. (2001) Classical and slow-binding inhibitors of human type II arginase. Biochemistry 40: 9356-9362.
71. Masuda, H., Yano, M., Sakai, Y., Kihara, K., Yamauchi, Y. & Azuma, H. (2004) Modulation of intrinsic cavernous tone and nitric oxide production by arginase in rabbit corpus cavernosum. J. Urol. 171: 490-494.
72. Cama, E., Colleluori, D. M., Emig, F.A., Shin, H., Kim, S. W., Kim, N. N., Traish, A. M., Ash, D. E. & Christianson, D. W. (2003) Human arginase II: crystal structure and physiological role in male and female sexual arousal. Biochemistry 22: 8445-8451.
73. Osanai, M. & Yonezawa, Y. (1984) Age-related changes in amino acid pool sizes in the adult silkmoth, Bombyx mori, reared at low and high temperature; a biochemical examination of the rate-of-living theory and urea accumulation when reared at high temperature. Exp. Gerontol. 19: 37-51.
74. Shukla, S. P. & Kanungo, M. S. (1969) Effect of age on the activity of arginase of the liver and kidney cortex of rat. Exp. Gerontol. 4: 57-60.
75. Zhang, C., Hein, T. W., Wang, W., Chang, C. I. & Kuo, L. (2001) Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB J. 15: 1264-1266.
76. Park, K., Goldstein, I., Andry, C., Siroky, M., Krane, R. J. & Azadzoi, K. (1997) Vasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int. J. Impot. Res. 9: 27-37.
77. Giraldi, A., Alm, P., Werkstrom, V., Myllymaki, L., Wagner, G. & Andersson, K. E. (2002) Morphological and functional characterization of a rat vaginal smooth muscle sphincter, Int. J. Impot. Res. 14: 271-282.
78. Giraldi, A., Persson, K., Werkstrom, V., Alm, P., Wagner, G. & Andersson, K. E. (2001) Effects of diabetes on neurotransmission in rat vaginal smooth muscle. Int. J. Impot. Res. 13: 58-66.
79. Min, K., O'Connell, L., Munarriz, R., Huang, Y. H., Choi, S., Kim, N., Goldstein, I. & Traish, A. (2001) Experimental models for the investigation of female sexual function and dysfunction. Int. J. Impot. Res. 13: 151-156.
80. Kim, S. W., Jeong, S. J., Munarriz, R., Kim, N. N., Goldstein, I. & Traish, A. M. (2003) Role of the nitric oxide-cyclic GMP pathway in regulation of vaginal blood flow. Int. J. Impot. Res. 15: 355-361.
81. Traish, A. M., Kim, N. N., Huang, Y. H., Min, K., Munarriz, R. & Goldstein, I. (2003) Sex steroid hormones differentially regulate nitric oxide synthase and arginase activities in the proximal and distal rabbit vagina. Int. J. Impot. Res. 15: 397-404.
82. Traish, A. M., Kim, N., Min, K., Munarriz, R. & Goldstein, I. (2002) Role of androgens in female genital sexual arousal: receptor expression, structure, and function. Fertil Steril. 77 (Suppl. 4): S11-S18.
83. Li, H., Meininger, C. J., Hawker, J. R. Jr., Haynes, T. E., Kepka-Lenhart, D., Mistry, S. K., Morris, S. M., Jr. & Wu, G. (2001) Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am. J. Physiol. 280: E75-E82.
84. Li, H., Meininger, C. J., Kelly, K. A., Hawker, J. R. Jr., Morris, S. M., Jr. & Wu, G. (2002) Activities of arginase I and II are limiting for endothelial cell proliferation. Am. J. Physiol. 282: R64-R69.
85. Cellek, S. & Moncada, S. (1998) Nitrergic neurotransmission mediates the non-adrenergic non-cholinergic responses in the clitoral corpus cavernosum of the rabbit. Br. J. Pharmacol. 125: 1627-1629.